Back to News
Market Impact: 0.2
Adma Biologics (ADMA) Just Overtook the 20-Day Moving Average
Source: zacks.com
Market Technicals & Flows
Adma Biologics reached an important support level and moved above resistance at its 20-day moving average, which the article says suggests a short-term bullish trend. The technical setup is described as a potentially attractive stock pick; no price target or expected return is provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
ADMA0.35
More News
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Asian Markets Tally Losses From Worsening Global Rout
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- FTSE 100 today: Stocks slump as global tech rout deepens